Belgian Healthtech Startup IntelliProve Secures €2.7 Million Seed Funding to Scale Camera-Based Health Monitoring

IntelliProve, a Belgian healthtech startup, has raised €2.7 million ($2.9 million) in seed funding to advance its software platform that transforms standard cameras into health-monitoring devices. The round was led by Miles Ahead, with participation from Wit-Gele Kruis, imec.istart, and business angels.

The funding underscores growing interest in accessible health-monitoring solutions that leverage existing hardware rather than requiring specialized equipment. IntelliProve’s technology enables smartphones, tablets, and other camera-equipped devices to function as biomarker sensors, potentially expanding remote health monitoring capabilities to populations with limited access to traditional diagnostic tools.

Expanding Datasets and Clinical Validation

The company plans to deploy capital toward multiple development priorities. Research and development efforts will focus on expanding its datasets across diverse skin tones, ages, and lighting conditions—addressing a persistent challenge in medical technology where algorithms trained on limited demographic diversity often perform inconsistently across populations. Improving biomarker accuracy represents another key objective, alongside pursuing Class IIa medical device certification, a regulatory milestone that would enable the technology to be marketed as a medical device in European markets.

IntelliProve’s founders view virtual-care partnerships as a near-term growth avenue. According to Joeri Tulkens, the company believes that “healthcare is at a tipping point. We believe the future of health monitoring is software-first, scalable and accessible to everyone. Our virtual care partners are not just experimenting with IntelliProve, they are building it into the core of their offering.”

Humanoid Robots as the Next Frontier

The funding also supports expansion into emerging applications, particularly humanoid and assistive robotics. Tulkens noted that “humanoid robots are next: they are becoming very good at understanding the world around them, and the next step is helping them understand the people within that world. This funding lets us make IntelliProve the health sensing layer for any camera, worldwide.”

This diversification reflects the company’s ambition to position its technology as infrastructure rather than a standalone product—a health-sensing capability that can be integrated across multiple platforms and devices as they proliferate.

European Innovation Momentum

IntelliProve’s funding comes amid broader momentum in European healthtech innovation, where startups are increasingly developing software-centric solutions that democratize access to medical diagnostics and monitoring. The company’s focus on dataset diversity and clinical validation also reflects maturing standards within the region, where regulators and investors increasingly scrutinize equity implications of AI-driven health technologies.

The Belgian startup’s trajectory illustrates how European founders are positioning themselves at the intersection of consumer devices, artificial intelligence, and healthcare delivery—segments where regulatory frameworks are still evolving but investor confidence continues to grow.

Leave a Comment